Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,600
Closed -$1.24M 991
2022
Q2
$1.24M Buy
+13,600
New +$1.21M 0.11% 317
2022
Q1
Sell
-16,037
Closed -$1.23M 1048
2021
Q4
$1.23M Buy
+16,037
New +$1.28M 0.09% 319
2021
Q2
Sell
-5,659
Closed -$416K 908
2021
Q1
$416K Sell
5,659
-68,539
-92% -$5.06M 0.03% 541
2020
Q4
$5.79M Sell
74,198
-33,368
-31% -$2.55M 0.39% 70
2020
Q3
$8.51M Buy
107,566
+33
+0% +$2.58K 0.56% 22
2020
Q2
$7.93M Buy
107,533
+3,356
+3% +$253K 0.54% 45
2020
Q1
$7.65M Buy
104,177
+1,945
+2% +$153K 0.61% 44
2019
Q4
$8.87M Buy
+102,232
New +$8.4M 0.55% 66
2015
Q4
Sell
-1,527,945
Closed -$72M 733
2015
Q3
$72M Buy
1,527,945
+903,706
+145% +$48M 1.61% 1
2015
Q2
$33.9M Buy
624,239
+608,611
+3,894% +$34.1M 0.89% 9
2015
Q1
$857K Buy
+15,628
New +$885K 0.02% 842
2014
Q4
Sell
-956,805
Closed -$54.1M 912
2014
Q3
$54.1M Buy
956,805
+237,751
+33% +$13.4M 1.37% 4
2014
Q2
$39.7M Buy
+719,054
New +$39.2M 1.06% 5
2013
Q4
Sell
-512,775
Closed -$23.3M 969
2013
Q3
$23.3M Buy
512,775
+236,167
+85% +$10.8M 0.63% 17
2013
Q2
$12.3M Buy
+276,608
New +$12.4M 0.3% 61

Other funds holding MRK

PDT Partners's MRK Position: Q3 2022 in Review

PDT Partners sold out of Merck (MRK) in Q3 2022, closing a stake of 13,600 shares — an estimated $1.24M sold.

PDT Partners first reported a position in MRK in Q2 2013 and held it in 15 quarters. The position peaked at $72M in Q3 2015. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • PDT Partners reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • PDT Partners sold 13,600 Merck shares in Q3 2022, an estimated $1.24M.
  • PDT Partners first reported a position in Merck in Q2 2013 and held it in 15 quarters.
  • PDT Partners's Merck position peaked at $72M in Q3 2015.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.